Crossmark

Isavuconazole in a Successful Combination Treatment of Disseminated Mucormycosis in a Child with Acute Lymphoblastic Leukaemia and Generalized Haemochromatosis: A Case Report and Review of the Literature

Crossref DOI link: https://doi.org/10.1007/s11046-018-0287-0

Published Online: 2018-07-23

Published Print: 2019-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pomorska, Anna https://orcid.org/0000-0002-5559-8543
Malecka, Anna

Jaworski, Radoslaw

Radon-Proskura, Julia

Hare, Rasmus Krøger

Nielsen, Henrik Vedel

Andersen, Lee O’Brian

Jensen, Henrik Elvang

Arendrup, Maiken Cavling

Irga-Jaworska, Ninela
License Information

Text and Data Mining valid from 2018-07-23
More Information

Article History

Received: 13 February 2018

Accepted: 2 July 2018

First Online: 23 July 2018

Compliance with Ethical Standards

:

: The authors declare that they have no conflict of interest.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.

: Informed consent for off-label isavuconazole administration was obtained from parents of our patient.

Document is current

Any future updates will be listed below